劳斯人民民主共和国社区药房的良好药房实践 - - 横截面研究
Soutthida Vongsavath1,2, Kimihiro Nishino1, Davone Duangdany2
1Department of Healthcare Administration, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.
只有11.7%的老社区药房符合良好的药房实践 (GPP) 标准. 城外药房和男性药剂师的执法率较低,这表明需要有针对性的支持来改善医疗保健.
科学领域:
- 制药科学
- 公共卫生
- 医疗服务研究
背景情况:
- 在像老人民共和国这样的低收入和中等收入国家, 社区药房是重要的初级医疗保健接入点.
- 良好的药房实践 (GPP) 准则为社区药房运营制定了基本标准.
研究的目的:
- 评估老人民共和国社区药房遵守GPP标准.
- 确定与低于最佳的GPP依守相关的因素.
主要方法:
- 这是一项涉及10个省份180家药房的横截面研究.
- 收集有关设施,储存,服务,发行,合理使用和药房/工作人员特征的数据.
- 使用描述性统计和后勤回归分析.
主要成果:
- 只有11.7%的药房达到80%的总GPP标准.
- 城市中心以外的药房的GPP遵守率较低9.29倍.
- 与女性药剂师相比,男性药剂师表现出低GPP的可能性是2. 38倍.
结论:
- 大多数老人民共和国社区药房的GPP遵守率较低.
- 农村地区和有男性员工的药房可能需要有针对性的干预措施.
- 有针对性的行政检查,指导和支持可以加强该地区的社区药房实践.
更多相关视频
19:57An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
09:58Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS
Published on: April 18, 2018
相关概念视频
Analysis of Population Pharmacokinetic Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Drug Distribution: Miscellaneous Factors
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Model Approaches for Pharmacokinetic Data: Physiological Models
